Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at CAGR of 8.2% during forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
With growing numbers of real-time PCR and qPCR consumers buying digital PCR because of the decrease in its cost, total quantification, better sensitivity, precision and better robustness; and with the qPCR and Digital PCR market projected to grow to US$ 4 billion by 2022, this conference delivers a timely occasion to learn first-hand about dPCR whereas also keeping up to date with latest enlargements and policies in qPCR and real-time PCR.
The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Clinical applications of PCRs. According to the data from Centers for Disease Control and Prevention (CDC), the amount of deaths because of cancers in U.S. was 575,000 in 2010 and estimated to rise to 630,000 in 2020. This is mostly because of morbid lifestyle, heredity, and others. So, growing number of cancer cases and associated deaths found to be one of the key causes for largest share of clinical application in global market.
North America is projected to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. Higher implementation of innovative technologies, well recognized healthcare research and diagnostic industries, growing funding for qPCR and dPCR technologies, rising incidence & prevalence of infective and genetic diseases, constant decrease in gene sequencing cost, and existence of key players in the region are responsible for largest share of North American market.
At the same time, Asia Pacific is projected to grow at a fastest CAGR because of rapidly emerging countries, rising aging population coupled with increasing incidence of genetic diseases, increase in government support for life science research, developing research & clinical trial outsourcing from the region, and increasing number of CROs.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Digital PCR (dPCR) and Real-time PCR (qPCR) Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Digital PCR (dPCR) and Real-time PCR (qPCR) Market.
DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/32992
Scope of Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market:
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product:
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Application:
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by End User:
• Diagnostic Labs
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Region:
• North America
• Asia Pacific
• Middle East & Africa
• South America
Key Players Operating in Market Include:
• Thermo Fisher Scientific, Inc.
• F. Hoffman-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Takara Bio, Inc.
• gilent Technologies, Inc.
• bioMérieux S.A.
• Fluidigm Corporation
• Danaher Corporation
• Abbott Laboratories
• Merck KGaA
• Becton Dickinson and Company
• Promega Corporation
• Eppendorf AG
• Analytik Jena AG
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Vikas Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact: +919607065656/ +919607195908